Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma.
2014
Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
53
Citations
NaN
KQI